School of Medicine
Showing 1-57 of 57 Results
-
Vasiliki Rahimzadeh
Postdoctoral Research Fellow, Biomedical Ethics
BioVasiliki (Vaso) Rahimzadeh, PhD is an applied bioethics scholar with research interests at the intersection of precision medicine, data governance and public policy.
-
Shamma Shakila Rahman
Postdoctoral Research Fellow, Human Gene Therapy
Current Research and Scholarly InterestsImmunological pathophysiology of Pediatric Acute-onset Neuropsychiatric Syndrome
-
Ali Rashidi
Postdoctoral Research Fellow, Radiology
BioAppointments:
Post-Doctoral Scholar and Research Scientist, Department of Radiology, Stanford University (June 2020-present)
Post-Doctoral Scholar and Research Scientist, Department of Radiology, John Hopkins University (August 2018 - May 2020) -
Shobha Regmi
Postdoctoral Research Fellow, Radiology
BioResearch interest: Mesenchymal stem cell transplantation, Stem cell biology, Islet transplantation, Biomaterials, Drug delivery
-
Junming Ren
Postdoctoral Research Fellow, Molecular and Cellular Physiology
Current Research and Scholarly InterestsImmune Engineering, Synthetic Medicine, Synthetic Immunology
-
Ehsan Rezaei
Postdoctoral Research Fellow, Molecular and Cellular Physiology
Current Research and Scholarly InterestsExperimental and computational studies of force transmission responsible for touch sensation on C. elegans nematode outer shell wall.
-
Izabela Mauricio Rezende
Postdoctoral Research Fellow, Infectious Diseases
BioI have a B.S. in Biology, M.Sc. in Immunology and Infectious diseases, Ph.D. in Microbiology, and a broad background in virology/microbiology and molecular biology applied to viral infectious diseases. I have a vast knowledge of classical virology, molecular biology, phylogenetic analysis, serological, and molecular diagnosis. I am working on recent YF outbreaks, focusing on viral dynamics, ecology, diagnosis, and the investigation of virological, immunological, and clinical aspects during the course of infection. We have supported the hospital and Secretary of Health of Minas Gerais with some laboratory testing applied to diagnosis of YF, viral genotyping related to YF patients suspected to have adverse events following vaccination, and other analysis. We also have been working on dynamics of the outbreak, on the virological, epidemiological, and immunological aspects during the course of yellow fever. During the COVID-19 pandemic, we also supported the Brazilian Ministry of Health with the SARS-CoV-2 diagnosis in human samples and also in the investigation of the SARS-CoV-2 RNA in surfaces of density public areas of Belo Horizonte. Since Nov/2018 I had been an editor in the journal Docência do Ensino Superior (RDES / GIZ / UFMG) and in Jan/2020 I became Editor-in-Chief.
-
Suman Rimal
Postdoctoral Research Fellow, Pathology
BioResearch interests: Genetic mechanism underlying mitochondrial pathology, neurodegeneration, and muscle loss using Drosophila as a model organism.
-
Tyler Risom
Postdoctoral Research Fellow, Pathology
BioMy work utilizes multiplexed ion beam imaging (MIBI) to understand how tumor cells, immune cells, and stromal cells interact in pre-invasive breast, lung, and prostate tumors, and specifically, which 'bad actors' may drive progression to invasive carcinoma. MIBI has the unparalleled ability to simultaneously measure 50+ markers in a single tumor region, allowing us to measure the many cell types that exist within tumors, how these cell types are spatially related, and how they change in frequency, identity, and signalling as tumors progress to invasive carcinoma. A better understanding of the cellular changes that support transition to invasive cancer will allow us to design clinical tests to identify which patients are at risk of progression, and which are not, allowing oncologists to spare tens of thousands patients per year with low-risk tumors the unnecessary surgery, chemotherapy, and radiation that may be of no benefit. Further, through these investigations I seek to identify new molecular targets that can prevent or halt tumor progression, allowing us to design therapeutics that can combat cancer at this early, sensitive state.
